瑞典南部马尔默多发性硬化症移民的患病率和疾病残疾
Lucía Alonso-Magdalena1, Olga Carmona I Codina2, Elisabet Zia3
1Department of Neurology, Skåne University Hospital and Department of Clinical Sciences, Lund University, Lund, Sweden.
Clinical neurology and neurosurgery
|March 29, 2024
概括
在马尔默的第一代移民中,多发性硬化症 (MS) 的患病率较低,但与斯堪的纳维亚人相比,非西方群体的疾病进展更严重. 这项研究强调了不同人群中多发性硬化症进展的潜在差异.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 多发性硬化症 (MS) 是年轻人残疾的主要原因.
- 移民研究表明,MS残疾的种族差异.
- 瑞典移民中的疾病进展仍未得到充分研究.
研究的目的:
- 为了确定在瑞典马尔默的第一代移民中MS的流行率.
- 为了比较移民群体和本地人口之间的多发性硬化症严重程度.
主要方法:
- 纳入截至2010年12月31日马尔默诊断患有多发性硬化症的所有个人.
- 根据出生国家对病例的分类:斯堪的纳维亚,西方和非西方.
主要成果:
- 原始的MS患病率为移民的100/100,000,斯堪的纳维亚人的154/100,000,西方移民的123/100,000,非西方移民的76/100,000.
- 虽然初始严重程度得分 (MSSS) 没有显著差异,但调整后的分析显示,非西方移民的疾病严重程度在统计上显著增加 (MSSS平均差异为1.7,p=0.030).
- 在各组之间,在诊断或治疗开始的时间内没有观察到显著差异.
结论:
- 与斯堪的纳维亚人口相比,马尔默的第一代移民的MS总体患病率较低.
- 非西方移民经历的MS比斯堪的纳维亚人更严重的疾病过程.
- 研究结果表明,多发性硬化症严重程度的潜在差异受地理来源的影响.
更多相关视频
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
10.7K
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
1.4K
相关概念视频
Prevalence and Incidence
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
